Consumer Staples·Personal Care Products·$2.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.03 | N/A | +68.03% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.03 | N/A | +68.03% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook regarding EPS growth. However, they did not offer specific guidance for future revenue.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to enhance brand visibility and market presence.
Interparfums Inc's strong EPS performance indicates effective cost management and possibly successful product launches. The stock's slight increase of 1.07% reflects investor approval of the earnings surprise. However, the lack of revenue data and guidance may leave some investors cautious about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ALNYLAM PHARMACEUTIC
May 6, 2013